CE认证
生物活化
Viscoderm 2.0 is a sterile injectable medical device by IBSA, indicated for bringing the dermis back to its normal physiological condition in cases of severe xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified healthcare professionals. The product contains 20 mg/ml of highly purified sodium hyaluronate obtained through fermentation.
主要优势： Viscoderm 2.0
- Sterile, single-use injectable medical device, CE 0477
- Highly purified sodium hyaluronate obtained by fermentation, not subjected to chemical modification processes
- Molecular weight of about 1 million Dalton, very close to endogenous hyaluronic acid, making the product totally biocompatible
- Rehydrates the tissues and favours tissue remodelling
- Indicated for severe xerodermia associated with dermatitis and/or psoriasis
- Sold on medical prescription only, for administration by qualified personnel
适应症与专业用途
主要适应症
- Severe xerodermia associated with dermatitis and/or psoriasis
- Restoration of the normal physiological condition of the dermis
- Rehydration of skin tissue where cell turnover of the stratum corneum is increased
专业用途
Viscoderm 2.0 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.
治疗部位
- Intradermal administration, at medium-deep level
- The treating practitioner determines the area treated
适用患者
Viscoderm 2.0 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 2.0% concentration is indicated to counteract severe xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.
作用原理： Viscoderm 2.0
Viscoderm 2.0 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 2.0% concentration is the highest of the three in the range and is the one indicated for severe xerodermia.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 VISCODERM 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
What is Viscoderm 2.0 indicated for?
It is indicated for adults of both sexes, for restoration of the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, with the 2.0% concentration indicated for the severe degree.
What is the treatment schedule?
An initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions.
Who should not be treated with Viscoderm 2.0?
It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.
更多产品： IBSA
医美护肤
皮肤填充剂
骨科
诊所替代选择
美塑疗法
水光针
/ 最近浏览
继续浏览
Viscoderm 2.0 is a sterile injectable medical device by IBSA, indicated for bringing the dermis back to its normal physiological condition in cases of severe xerodermia associated with dermatitis and/or psoriasis. It is intended for intradermal administration by qualified healthcare professionals. The product contains 20 mg/ml of highly purified sodium hyaluronate obtained through fermentation.
主要优势： Viscoderm 2.0
- Sterile, single-use injectable medical device, CE 0477
- Highly purified sodium hyaluronate obtained by fermentation, not subjected to chemical modification processes
- Molecular weight of about 1 million Dalton, very close to endogenous hyaluronic acid, making the product totally biocompatible
- Rehydrates the tissues and favours tissue remodelling
- Indicated for severe xerodermia associated with dermatitis and/or psoriasis
- Sold on medical prescription only, for administration by qualified personnel
适应症与专业用途
主要适应症
- Severe xerodermia associated with dermatitis and/or psoriasis
- Restoration of the normal physiological condition of the dermis
- Rehydration of skin tissue where cell turnover of the stratum corneum is increased
专业用途
Viscoderm 2.0 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.
治疗部位
- Intradermal administration, at medium-deep level
- The treating practitioner determines the area treated
适用患者
Viscoderm 2.0 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 2.0% concentration is indicated to counteract severe xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.
作用原理： Viscoderm 2.0
Viscoderm 2.0 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 2.0% concentration is the highest of the three in the range and is the one indicated for severe xerodermia.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 VISCODERM 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
What is Viscoderm 2.0 indicated for?
It is indicated for adults of both sexes, for restoration of the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, with the 2.0% concentration indicated for the severe degree.
What is the treatment schedule?
An initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions.
Who should not be treated with Viscoderm 2.0?
It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.
更多产品： IBSA
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。